Aardvark Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aardvark Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aardvark Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aardvark Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $9.2k | 1.8k | 5.18 |
| 2026-03-31 | $24k | 6.6k | 3.64 |
| 2025-09-30 | $31k | 2.3k | 13.29 |
| 2025-03-31 | $23k | 3.1k | 7.51 |